CEACAM5 and neoplasm: This finding implies that patients with longer overall survival periods are positively correlated with anti-tumor scores for certain signature genes with high expression (CCKBR, KCNJ11, ITGA10, and IGFBP1) and other signature genes with low expression (NMU, MMP13 and CEACAM5).